Nuclear size, shape and summed optical density in endometrial cancer

International Journal of Gynecological Cancer

Volumn 7, Issue 2, 1997, Pages 139-143

  Geisler, J P ^a   Wiemann, M C ^a   Zhou, Z ^b   Miller, G A ^b   Geisler, H E ^a,b  

^a ST VINCENT HOSPITAL   (United States)

^b Lab Diagn and Analyt Cytometry   (United States)

Author keywords

endometrial cancer; image analysis; nuclear morphometry; recurrence

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CELL NUCLEUS; CELL SHAPE; CELL SIZE; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030926681     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00435.x     Document Type: Article

References (24)

1. DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology, 4th edn. St. Louis: Mosby Year Book, 1993: 156-93.
2. Creasman ET, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1972; 110: 773-81.
3. Hanson MB, Van Nagell JR, Powell DE, et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985; 55: 1753-7.
4. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB. Endometrial carcinoma: a multiparameter clinicopathologic analysis including the DNA profile and the sex steroid status. Cancer 1986; 58: 1518-25.
5. Iversen OE. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986; 155: 770-6.
6. Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC. DNA ploidy in endometrial carcinoma: major objective prognostic factor. Mayo Clin Proc 1990; 65: 643-50.
7. Newbury R, Schuerch C, Goodspeed N, Farming J, Glidewell O, Evans M. DNA content as a prognostic factor in endometrial carcinoma. Obstet Gynecol 1990; 76: 251-7.
8. Moberger B, Auer G, Forsslund G, Moberger G. The prognostic significance of DNA measurements in endometrial carcinoma. Cytometry 1984; 5: 430-6.
9. Sorbe B, Risberg B, Thornthwaite J. Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer 1994; 4: 94-100.
10. Atkin B. Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus. JNCI 1976; 56: 909-10.
11. Baak JPA, Kurver PHJ, Overdiep SH, et al. Quantitative, microscopical, computer-aided diagnosis of endometrial hyperplasia or carcinoma in individual patients. Histopathology 1981; 5: 689-95.
12. Tezuka F, Chiba R, Tkahashi T. Morphometric and multivariate statistical detection of cancer cells in endometrial cytology. Analyt Quant Cytol Histol 1994; 16: 332-8.
13. Baak JP. The principles and advances of quantitative pathology. Analyt Quant Cytol Histol 1994; 9: 89-95.
14. Geisler JP, Zhou Z, Miller GA, Wiemann MC, Geisler HE. Markov texture parameters as prognostic indicators in endometrial cancer. Gynecol Oncol 1996; 62: 174-80.
15. Mendelsohn ML, Mayall BH. Chromosome identification by image analysis and quantitative cytochemistry. In: Junis JJ, ed. Human Chromosome Methodology, 2nd edn. New York: Academic Press, 1974: 311-46.
16. Bacus JW, Grace LJ. Microscope system for standardized cell measurements and analyses. Appl Optics 1987; 26: 3280-93.
17. Pressman NJ. Markovian analysis of cervical cell images. J Histochem Cytochem 1976; 24: 138-44.
18. Russack V. Image cytometry: current applications and future trend. Crit Rev Clin Labor Scien 1994; 31: 1-34.
19. Weger AR, Lindholm J, Glaser K, Mairinger T, Mikuz G. Morphometry and prognosis in cancer of the pancreatic head. Path Res Pract 1992; 188: 764-9.
20. Epstein JI, Berry SJ, Eggleston JC. Nuclear roundness factor: a predictor of progression in untreated stage A2 prostate cancer. Cancer 1984; 54: 1666-71.
21. Miller B, Umpierre S, Tornos C, Burke T. Histologic characterization of uterine papillary serous adenocarcinomas. Gynecol Oncol 1995; 56: 425-9.
22. Ausems EW, van der Kamp JK, Baak JP. Nuclear morphometry in the determination of the prognosis of marked atypical endometrial hyperplasia. Int J Gynecol Pathol 1985; 4: 180-5.
23. Baak JP, Langley FA, Talerman A, Delemarre JF. The prognostic variability of ovarian tumor grading by different pathologists. Gynecol Oncol 1987; 27: 166-72.
24. Baak JP. The use and disuse of morphometry in the diagnosis of endometrial hyperplasia and carcinoma. Pathol Res Pract 1984; 179: 20-3.